Since pre-treatment with anakinra significantly reduced the levels of chemokines (CXCL8 and CCL2) in both FaDu and UPCI-SCC90 tumour-stromal models (Figure 4), we reasoned that these anakinra-treated tumour-stromal models would therefore also recruit fewer leukocytes. The gene discussed is CXCL8; the disease is neoplasm.